ISPR

ISPR is a vaping-hardware ODM whose business is going backwards on every axis that matters. FY2025 revenue fell 16.1% to $127M after years of growth (FY24 $152M), driven by a collapse in the U.S. market — product sales there nearly halved from $63.1M to $32.6M — and the company is now leaning on Europe (58% of revenue) to stay afloat. Worse, the loss is accelerating violently: net loss swung from -$14.8M to -$39.2M (-165.7%) and operating margin sank to -29.7% as operating expenses jumped to 47.5% of revenue. Gross margin also slipped to 17.8% from 19.6%, and with cost of goods sourced almost entirely from a single supplier (Shenzhen Yi Jia), there is little margin cushion or supply-chain leverage.

The balance sheet is the decisive red flag. Stockholders' equity has been all but erased — down 98.2% to just $605K against $102M of liabilities, a liabilities/equity ratio of 168x and a deeply negative -$48.1M retained-earnings deficit. The MD&A reveals why: the allowance for credit losses tripled from $5.9M to $18.0M in one year, meaning a large slice of the reported revenue is uncollectible and management's own customers can't or won't pay. That is a quality-of-revenue problem, not a one-off. With $24.4M cash and operating cash flow of -$7.37M, the company is not on the immediate brink, but a single bad quarter or further receivable write-offs could force another dilutive raise — and it has already tapped equity markets three times since the 2023 IPO (most recently at $6.00, versus $1.21 today).